Arkolith/Insider Trading/MIRM/Form 4

Bjerkholt Eric

CHIEF FINANCIAL OFFICERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jun 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$469K
Net Open-Market Flow
-$469K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2026Option exercise(M)2K$26.49$63K47K
Jun 8, 2026Sell(S)2K$92.84$210K48K
Jun 8, 2026Sell(S)1K$93.95$110K46K
Jun 8, 2026Sell(S)2K$95.12$149K45K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 9, 2026Option exercise(M)2K—$027K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001197350-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML